The Journal of Immunology, Vol 153, Issue 4 1858-1868, Copyright © 1994 by American Association of Immunologists

ARTICLES

Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates

T Lehner, LA Bergmeier, L Tao, C Panagiotidi, LS Klavinskis, L Hussain, RG Ward, N Meyers, SE Adams and AJ Gearing
Department of Immunology, United Medical School, Guy's Hospital, London, United Kingdom.

A s.c. route of immunization was developed in non-human primates, which targets the genitourinary-rectal associated lymphoid tissue. A vaccine consisting of rSIV gag p27, expressed as hybrid Ty virus-like particles (p27: Ty-VLP) was administered in the proximity of the internal iliac lymph nodes. Secretory IgA and IgG Abs to the p27 Ag were elicited in the vaginal, male urethral, rectal and seminal fluids, urine and serum. Two or more immunodominant B cell epitopes were identified within peptides 51-90 and 121-170 of the sequence of p27, using serum or biliary IgA and IgG Abs. CD4+ T cell proliferative responses to p27 were elicited predominantly in the targeted internal iliac, as well as the inferior mesenteric lymph nodes and the spleen, but not in the unrelated lymph nodes. These cells were then studied for helper function in p27 specific B cell Ab synthesis. Specific IgA and IgG Abs were detected in the same lymphoid tissues as those that displayed proliferative responses. However, cross-over reconstitution experiments between splenic and iliac lymph node B and CD4+ T cells suggest that the iliac B cells are essential for specific IgA Ab synthesis, whereas splenic B cells preferentially synthesize IgG Ab. The targeted lymph node (TLN) route of immunization gave comparable B cell, proliferative T cell, and Th cell responses to the vaginal, male genitourinary, and rectal mucosal routes, which were augmented by oral immunization. However, the TLN route induced urinary and seminal fluid sIgA and IgG Abs in addition to genital and rectal Abs. Generating secretory IgA and IgG Abs at the mucosal surfaces, and T and B cell immunity in the regional draining lymph nodes, spleen and circulation by TLN immunization may prevent transmission of virus through the mucosa, dissemination of the virus, and the formation of a latent reservoir of infection.

This article has been cited by other articles:

				J. M. Thompson, M. G. Nicholson, A. C. Whitmore, M. Zamora, A. West, A. Iwasaki, H. F. Staats, and R. E. Johnston Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node J. Immunol., July 1, 2008; 181(1): 574 - 585. [Abstract] [Full Text] [PDF]

				M. Corbett, W. M. Bogers, J. L. Heeney, S. Gerber, C. Genin, A. Didierlaurent, H. Oostermeijer, R. Dubbes, G. Braskamp, S. Lerondel, et al. Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic PNAS, February 12, 2008; 105(6): 2046 - 2051. [Abstract] [Full Text] [PDF]

				L.A. Bergmeier and T. Lehner Innate and Adaptive Mucosal Immunity in Protection against HIV Infection Advances in Dental Research, April 1, 2006; 19(1): 21 - 28. [Abstract] [Full Text] [PDF]

				A. Yoshida, R. Tanaka, T. Murakami, Y. Takahashi, Y. Koyanagi, M. Nakamura, M. Ito, N. Yamamoto, and Y. Tanaka Induction of Protective Immune Responses against R5 Human Immunodeficiency Virus Type 1 (HIV-1) Infection in hu-PBL-SCID Mice by Intrasplenic Immunization with HIV-1-Pulsed Dendritic Cells: Possible Involvement of a Novel Factor of Human CD4+ T-Cell Origin J. Virol., August 15, 2003; 77(16): 8719 - 8728. [Abstract] [Full Text] [PDF]

				L. Musey, Y. Ding, M. Elizaga, R. Ha, C. Celum, and M. J. McElrath HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals J. Immunol., July 15, 2003; 171(2): 1094 - 1101. [Abstract] [Full Text] [PDF]

				T. Lehner, C. Doyle, Y. Wang, K. Babaahmady, T. Whittall, L. Tao, L. Bergmeier, and C. Kelly Immunogenicity of the Extracellular Domains of C-C Chemokine Receptor 5 and the In Vitro Effects on Simian Immunodeficiency Virus or HIV Infectivity J. Immunol., June 15, 2001; 166(12): 7446 - 7455. [Abstract] [Full Text] [PDF]

				S.-W. Wang, P. A. Kozlowski, G. Schmelz, K. Manson, M. S. Wyand, R. Glickman, D. Montefiori, J. D. Lifson, R. P. Johnson, M. R. Neutra, et al. Effective Induction of Simian Immunodeficiency Virus-Specific Systemic and Mucosal Immune Responses in Primates by Vaccination with Proviral DNA Producing Intact but Noninfectious Virions J. Virol., November 15, 2000; 74(22): 10514 - 10522. [Abstract] [Full Text]

				S. Kawabata, Y. Terao, T. Fujiwara, I. Nakagawa, and S. Hamada Targeted Salivary Gland Immunization with Plasmid DNA Elicits Specific Salivary Immunoglobulin A and G Antibodies and Serum Immunoglobulin G Antibodies in Mice Infect. Immun., November 1, 1999; 67(11): 5863 - 5868. [Abstract] [Full Text] [PDF]

				B. Guy, S. Fourage, C. Hessler, V. Sanchez, and M. J. Q. Millet Effects of the Nature of Adjuvant and Site of Parenteral Immunization on the Serum and Mucosal Immune Responses Induced by a Nasal Boost with a Vaccine Alone Clin. Vaccine Immunol., September 1, 1998; 5(5): 732 - 736. [Abstract] [Full Text]